Pathophysiology of congestive heart failure
- PMID: 12776009
Pathophysiology of congestive heart failure
Abstract
Heart failure is a clinical syndrome characterized by impaired structure and/or function of the heart, leading to dyspnea and fatigue at rest or with exertion. The pathophysiology of heart failure is complex, and there is no single lesion. Any form of heart disease can lead to heart failure. Most heart failure can be explained by well-recognized etiologic factors, though ostensibly healthy patients may harbor risk factors for the later development of heart failure. A fundamental response to myocardial injury or altered loading conditions includes "remodeling" of the heart, so that the size, shape, and function of the affected chamber is grossly distorted. This is accompanied by a constellation of biologic changes, best recognized in advanced cases of heart failure. These multiple alterations may be primary or secondary events but, nonetheless, add importantly to the morbidity and mortality of the patients. More emphasis should be placed on recognition and correction of risk factors related to the development of heart failure.
Similar articles
-
Advanced systolic heart failure: emerging pathophysiology and current management.Prog Cardiovasc Nurs. 1998 Summer;13(3):14-30. Prog Cardiovasc Nurs. 1998. PMID: 9950020 Review.
-
Pathophysiology of congestive heart failure secondary to congestive and ischemic cardiomyopathy.Cardiovasc Clin. 1988;19(1):57-74. Cardiovasc Clin. 1988. PMID: 3048687 Review.
-
[Influence of pacing site on myocardial transmural dispersion of repolarization in intact normal and dilated cardiomyopathy dogs].Sheng Li Xue Bao. 2003 Dec 25;55(6):722-30. Sheng Li Xue Bao. 2003. PMID: 14695492 Chinese.
-
Surgery for the failing heart after myocardial infarction.Anadolu Kardiyol Derg. 2008 Nov;8 Suppl 2:93-100. Anadolu Kardiyol Derg. 2008. PMID: 19028641 Review.
-
[Clinical aspects and follow-up in dilated cardiomyopathy].Z Kardiol. 1995;84 Suppl 4:39-40. Z Kardiol. 1995. PMID: 8585272 Review. German.
Cited by
-
The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications.Int J Mol Sci. 2022 Dec 27;24(1):446. doi: 10.3390/ijms24010446. Int J Mol Sci. 2022. PMID: 36613900 Free PMC article.
-
Increase in PKCα Activity during Heart Failure Despite the Stimulation of PKCα Braking Mechanism.Int J Mol Sci. 2020 Apr 7;21(7):2561. doi: 10.3390/ijms21072561. Int J Mol Sci. 2020. PMID: 32272716 Free PMC article.
-
Pharmacogenomics in heart failure: where are we now and how can we reach clinical application?Cardiol Rev. 2014 Sep-Oct;22(5):193-8. doi: 10.1097/CRD.0000000000000028. Cardiol Rev. 2014. PMID: 25093738 Free PMC article. Review.
-
Epidemiological profile and obstetric outcomes of patients with peripartum congestive heart failure in Taiwan: a retrospective nationwide study.BMC Pregnancy Childbirth. 2017 Sep 12;17(1):302. doi: 10.1186/s12884-017-1486-2. BMC Pregnancy Childbirth. 2017. PMID: 28899350 Free PMC article.
-
Rodent models of heart failure: an updated review.Heart Fail Rev. 2013 Mar;18(2):219-49. doi: 10.1007/s10741-012-9305-3. Heart Fail Rev. 2013. PMID: 22446984 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical